A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

Brett W. Stringer, Bryan W. Day, Rochelle C.J. D’Souza, Paul R. Jamieson, Kathleen S. Ensbey, Zara C. Bruce, Yi Chieh Lim, Kate Goasdoué, Carolin Offenhäuser, Seçkin Akgül, Suzanne Allan, Thomas Robertson, Peter Lucas, Gert Tollesson, Scott Campbell, Craig Winter, Hongdo Do, Alexander Dobrovic, Po Ling Inglis, Rosalind L. JeffreeTerrance G. Johns, Andrew W. Boyd

Research output: Contribution to journalArticlepeer-review

114 Citations (Scopus)
63 Downloads (Pure)


Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet entrenched, poorly-representative cell line models are still widely used, compromising the significance of much GBM research. We submit that greater adoption of these critical resources will be promoted by the provision of a suitably-sized, meaningfully-described reference collection along with appropriate tools for working with them. Consequently, we present a curated panel of 12 readily-usable, genetically-diverse, tumourigenic, patient-derived, low-passage, serum-free cell lines representing the spectrum of molecular subtypes of IDH-wildtype GBM along with their detailed phenotypic characterisation plus a bespoke set of lentiviral plasmids for bioluminescent/fluorescent labelling, gene expression and CRISPR/Cas9-mediated gene inactivation. The cell lines and all accompanying data are readily-accessible via a single website, Q-Cell (qimrberghofer.edu.au/q-cell/) and all plasmids are available from Addgene. These resources should prove valuable to investigators seeking readily-usable, well-characterised, clinically-relevant, gold-standard models of GBM.

Original languageEnglish
Article number4902
Number of pages14
JournalScientific Reports
Publication statusPublished - Dec 2019
Externally publishedYes

Bibliographical note

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.


  • molecular targets
  • glioblastoma
  • xenografts


Dive into the research topics of 'A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma'. Together they form a unique fingerprint.

Cite this